Research published in the Journal of Parkinson's Disease has revealed that intravenous glutathione may help reduce symptoms in some Parkinson's patients by shielding dopamine-producing neurons from oxidative damage
If you wish to share your experience about your care and treatment or on behalf of a patient, please contact The Patient Experience Department who will advise you on how best to do this
It also reported the operation of secondary effects within the antioxidant system
Uno H, Kurata S
GSH deficiency as evidenced by a decrease in the GSH/GSSG ratio manifests itself largely through an increased susceptibility to oxidative stress, and the resulting damage is thought to be involved in SARS-CoV-2 infection leading to COVID-19 disease (6, 7, 39, 4353)
Gonzalez-Gonzalez O, Ramirez IO, Ramirez BI, O'Connell P, Ballesteros MP, Torrado JJ